SK

Safiya Kanakkassery Abdul Khadar

Active Director Director DIN 11346190
DIN 11346190 First appointment Oct 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Safiya Kanakkassery Abdul Khadar

Data last updated:

Safiya Kanakkassery Abdul Khadar is a Director at Medcore Medical Centre Private Limited (since 2025).

DIN 11346190
Primary Designation Director
First Appointment 17 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Oct 20252025Active

Board colleagues of Safiya Kanakkassery Abdul Khadar

Directorship timeline

Open interactive timeline →
Medcore Medical Centre Private Limited
Premium access

Shareholding and investment profile for Safiya Kanakkassery Abdul Khadar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Safiya Kanakkassery Abdul Khadar

Safiya Kanakkassery Abdul Khadar currently holds 1 directorship: Medcore Medical Centre Private Limited (Director, since 17 Oct 2025).

Safiya Kanakkassery Abdul Khadar was first appointed on 17 Oct 2025 as Director at Medcore Medical Centre Private Limited.

The current boards of Safiya Kanakkassery Abdul Khadar's companies include Mohamed Rafeeq Nandoli (Medcore Medical Centre Private Limited), Moosa Pallikkathodi Erathali (Medcore Medical Centre Private Limited), Sulafa Kannamthodi (Medcore Medical Centre Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available